November 12, 2013 -
As a result of this work, the company says device manufacturers will be able to use the BIO-key algorithm to match fingerprints on compatible AMD devices, with or without a server, or in the network or cloud.
Specifically, AMD customers will be using BIO-key’s scanner independent algorithm.
“BIO-key is honored to be working with AMD toward this uniquely valuable TrustZone integration,” said Jim Sullivan, BIO-key’s VP of Strategy and Business Development said. “With this solution, OEMs will be insulated from the rapidly changing fingerprint scanner marketplace by having a single best-of-breed, interoperable platform to interface with. Online service providers and enterprises will benefit from a standardized, securely configured WEB-key client on their users’ devices, made available by device manufacturers or through the ARM TrustZone technology ecosystem. This will allow enhanced security for online transactions and BYOD security. Fingerprint scanner manufacturers benefit by being part of a secure cloud infrastructure allowing remote and cloud authentication, which significantly enhances the core value proposition of fingerprint authentication beyond unlocking the phone or other device. Our existing patents on securing biometric data and keys using Trusted Execution Environments (TEE) make this a natural evolution of our product strategy.”
Tomorrow, November 13, 2013, BIO-key will present at the 2013 AMD Developer Summit with its presentation titled, “Leveraging fingerprint biometric authentication to streamline secure access.”
“AMD is pleased to be working with BIO-key to deliver flexibility in platforms utilizing biometrics for security and authentication,” Steve Belt, corporate Vice President of Strategic Alliances and Solution Enablement, AMD said. “BIO-key’s WEB-key platform gives customers the ability to choose hardware and software components which best meet the needs and form factor design points of their solutions, while also providing robust use cases through the use of ARM TrustZone technology and other open industry standards.”
Reported previously, earlier this week, BIO-key completed a private direct placement, raising $3.7 million in equity capital.